PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
SMi Group

Press Release


Receive press releases from SMi Group: By Email RSS Feeds:

SMi Releases a Quick Fire Interview with Dr. Prabhavathi Fernandes, President & CEO of Cempra Pharmaceuticals


The industry established event “Superbugs & Superdrugs” returns to London on 16th-17th March 2016 for its 18th annual show and is proud to have Dr. Prabhavathi Fernandes as one of the keynote speakers for 2016.

London, United Kingdom, December 17, 2015 --(PR.com)-- In the run up to Superbugs & Superdrugs 2016, SMi Group spoke to Dr. Fernandes about industry developments and her upcoming presentation entitled ‘Developing an antibiotic with potential for use in multiple therapeutic indications’.

“I am the President, CEO and Founder of Cempra, founded in 2006 and a public company 9NASDAQ) since 2012.At Cempra we have taken a macrolide antibiotic from lead selection to the NDA…I have had a history of antibiotic development and have worked in Pharma since 1980.” – Dr Prabhavathi Fernandes

The full interview is available to read in the event download centre www.smi-online.co.uk/goto/2016superdrugssuperbugs2.asp?tab=downloads

Author of numerous publications, Dr. Fernandes is Founder, President & CEO of Cempra Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing antibacterials. Her previous experience includes senior positions in areas such as drug discovery and microbiology at Bristol-Myers Squibb and Abbott Laboratories. During these years she was directly involved in the development of numerous antibiotics, four of which have been approved by the FDA and one achieving sales over a billion dollars.

The line-up joining Dr. Prabhavathi Fernandes at Superbugs and Superdrugs 2016 include elite international speakers from Transcrip Partners, Chemical Biology Ventures, European Commission, BARDA, Centre for Anti-Infective Agents, Spero Therapeutics, Arsanis, Da Volterra, Blueberry Therapeutics, Nemesis Bioscience, Cantab Anti-Infectives and many more.

For further details or to register, visit the event website at www.superbugssuperdrugs.com/prcom or contact Fateja Begum on: +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk

For those who are interested in attending, a £200 early bird saving is currently available online which expires on December 18th.

18th annual conference: Superbugs & Superdrugs
16-17 March 2016
Holiday Inn Kensington Forum, London UK
www.superbugssuperdrugs.com/prcom

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at www.smi-online.co.uk
Contact Information
SMi Group
Teri Arri
+44 20 7827 6000
Contact
http://www.superbugssuperdrugs.com/prcom

Click here to view the list of recent Press Releases from SMi Group
Promote Your Business